ANXA5 and hepatocellular carcinoma: In cirrhotic patients without HCC, an Annexin A5 threshold of >4.61 ng/mL achieved an AUC of 0.882 for predicting thrombosis, while in those with HCC, the AUC was 0.867, highlighting its sensitivity as an early marker of prothrombotic imbalance [85].